HIGHLIGHTS
- who: Rebecca Elyanow and colleagues from the Adaptive Biotechnologies, Seattle, Washington, USA Stanford University have published the Article: C L I N I C A L M E D I C I N E, in the Journal: (JOURNAL) of May/10,/2021
- what: In the present study, to better characterize the T_cell response to SARS-CoV-2 and assess the advantages and limitations of TCR testing relative to other modalities, the authors have analyzed blood samples from a prior study collected up to 6 months after symptom onset as part of a convalescent plasma donor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.